Literature DB >> 15118850

A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands.

Christina Bade-Doeding1, Holger-Andreas Elsner, Britta Eiz-Vesper, Axel Seltsam, Ute Holtkamp, Rainer Blasczyk.   

Abstract

In this study we have sequenced peptides eluted from a truncated recombinant HLA-A*6602 molecule, and compared their features with data reported for peptides presented in the A*6601 molecule. A striking change in the amino-acid binding preferences was observed at peptide position P1, which interacts with pocket A of the HLA peptide-binding region. For A*6601, aspartic acid and glutamic acid, both of which possess polar acidic side-chains, have been described as auxiliary anchors. This is in marked contrast to A*6602, where we observed serine, which has a neutral polar side-chain, as auxiliary anchor at P1. Accordingly, this shift in the physico-chemical properties of the auxiliary anchor may be best explained by the HLA amino-acid polymorphism at position 163, where arginine (hydrophilic, alkaline) in A*6601 has been replaced by glutamic acid in A*6602. This amino-acid exchange results in a shift towards higher acidity in pocket A, apparently resulting in the loss of preference for acidic auxiliary anchors, and leading to the preference for the neutral amino acid serine. The change of the auxiliary anchor residue at P1 is likely to alter the spectrum of peptides presented by A*6602 compared with A*6601, which may result in allogenicity in the case of a mismatch in allogeneic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118850     DOI: 10.1007/s00251-004-0677-y

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  36 in total

1.  The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity.

Authors:  M G Rudolph; J A Speir; A Brunmark; N Mattsson; M R Jackson; P A Peterson; L Teyton; I A Wilson
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

Review 2.  MHC class I molecules, structure and function.

Authors:  K Natarajan; H Li; R A Mariuzza; D H Margulies
Journal:  Rev Immunogenet       Date:  1999

3.  Incompatible differences: view of an allogeneic pMHC-TCR complex.

Authors:  D M Kranz
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

4.  HLA-B15 peptide ligands are preferentially anchored at their C termini.

Authors:  K R Prilliman; K W Jackson; M Lindsey; J Wang; D Crawford; W H Hildebrand
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

5.  Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.

Authors:  K C Parker; M A Bednarek; L K Hull; U Utz; B Cunningham; H J Zweerink; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

6.  Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.

Authors:  K Falk; O Rötzschke; M Takiguchi; V Gnau; S Stevanović; G Jung; H G Rammensee
Journal:  Int Immunol       Date:  1995-02       Impact factor: 4.823

7.  MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming.

Authors:  M Hirosawa; M Hoshida; M Ishikawa; T Toya
Journal:  Comput Appl Biosci       Date:  1993-04

8.  Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.

Authors:  K Fleischhauer; D Avila; F Vilbois; C Traversari; C Bordignon; H J Wallny
Journal:  Tissue Antigens       Date:  1994-11

9.  Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules.

Authors:  K Falk; O Rötzschke; M Takiguchi; B Grahovac; V Gnau; S Stevanović; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions.

Authors:  Laura Sesma; Verónica Montserrat; Jose Ramón Lamas; Anabel Marina; Jesús Vázquez; José A López de Castro
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

View more
  13 in total

1.  Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy.

Authors:  A Bajor; S Tischer; C Figueiredo; M Wittmann; S Immenschuh; R Blasczyk; B Eiz-Vesper
Journal:  Clin Exp Immunol       Date:  2011-06-03       Impact factor: 4.330

2.  Position 45 influences the peptide binding motif of HLA-B*44:08.

Authors:  Soumya Badrinath; Trevor Huyton; Heike Schumacher; Rainer Blasczyk; Christina Bade-Doeding
Journal:  Immunogenetics       Date:  2011-10-19       Impact factor: 2.846

3.  Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09.

Authors:  Trevor Huyton; Heike Schumacher; Rainer Blasczyk; Christina Bade-Doeding
Journal:  Immunogenetics       Date:  2012-06-16       Impact factor: 2.846

4.  The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.

Authors:  Christina Bade-Döding; Alex Theodossis; Stephanie Gras; Lars Kjer-Nielsen; Britta Eiz-Vesper; Axel Seltsam; Trevor Huyton; Jamie Rossjohn; James McCluskey; Rainer Blasczyk
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

5.  Peptide-binding motif of HLA-A*6603.

Authors:  Christina Bade-Doeding; Britta Eiz-Vesper; Constanca Figueiredo; Axel Seltsam; Holger-Andreas Elsner; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2004-12-08       Impact factor: 2.846

6.  A modular concept of HLA for comprehensive peptide binding prediction.

Authors:  David S DeLuca; Barbara Khattab; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2006-11-22       Impact factor: 2.846

7.  Large-scale characterization of peptide-MHC binding landscapes with structural simulations.

Authors:  Chen Yanover; Philip Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-08       Impact factor: 11.205

8.  The nature of peptides presented by an HLA class I low expression allele.

Authors:  Jan Hinrichs; Daniel Föll; Christina Bade-Döding; Trevor Huyton; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

9.  Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants.

Authors:  Christina Bade-Doeding; David S DeLuca; Axel Seltsam; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Immunogenetics       Date:  2007-02-10       Impact factor: 2.846

10.  HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.

Authors:  Thomas Kraemer; Alexander A Celik; Trevor Huyton; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  Stem Cells Int       Date:  2015-08-12       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.